Health / Medical Topics

    Agonistic anti-CD40 monoclonal antibody ADC-1013

    A human immunoglobulin (Ig) G1 monoclonal antibody directed against the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. Upon intratumoral administration, agonistic anti-CD40 monoclonal antibody ADC-1013 binds to CD40 on antigen-presenting dendritic cells, which leads to the activation and proliferation of effector and memory T-cells, and enhances the immune response against tumor cells. In addition, this agent binds to the CD40 antigen present on the surfaces of tumor cells, which induces antibody-dependent cytotoxicity (ADCC). This eventually inhibits the proliferation of CD40-expressing tumor cells. CD40, a stimulatory receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed on various immune cells, such as macrophages, dendritic cells and various tumor cell types; it plays a key role in the activation of the immune system. (NCI Dictionary)




    YOU MAY ALSO LIKE

    A drug or substance that binds to a receptor inside a cell or on its surface and causes the same action as…
    A rare disorder characterized by the lack of ability to recognize individuals, objects, shapes, sounds, or smells. There is no loss of…
    A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as…
    An adenoviral vector engineered to express the herpes simplex virus thymidine kinase (HSV-tk) gene, which, when administered in conjunction with a synthetic…
    A condition in which a person is unable to relax and be still. The person may be very tense and irritable, and…
    Any physiological aspect of aging; irreversible changes in an organism that occur over time and lead to a more mature condition. …

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact